Literature DB >> 2810277

IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.

J C Atkinson1, P C Fox, W D Travis, E Popek, R W Katz, J E Balow, S R Pillemer.   

Abstract

IgA rheumatoid factor (RF) and immune complexes containing IgA-IgG, C3-IgA, and C3-IgG from sera of patients with primary Sjögren's syndrome and controls were quantified by ELISA. Salivary tissue obtained from patients at the same time as serum was scored to simultaneously reflect lymphoplasmocytic infiltrate and fibrosis. Patients had significantly increased amounts of IgA RF and all complexes when compared to controls (p less than 0.0005). IgA-IgG complexes, thought to be IgG-IgA RF complexes, were inversely correlated to tissue pathology (p less than 0.001) and peripheral white blood cell counts. Additionally, IgA RF was inversely correlated to stimulated parotid flow. This suggests immune complex formation precedes tissue destruction or is associated with less destructive pathology in primary Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810277

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.

Authors:  K E Elagib; M Børretzen; R Jonsson; H J Haga; J Thoen; K M Thompson; J B Natvig
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Epidermal cell surface-associated IgG in patients with primary Sjögren's syndrome: in vitro evidence for immune complex binding.

Authors:  P Oxholm; A Oxholm; B S Thomsen; L Braathen
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome.

Authors:  Ralph Yachoui; Chady Leon; Kajal Sitwala; Mazen Kreidy
Journal:  Clin Med Res       Date:  2017-05-09

4.  Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.

Authors:  Hans-Jacob Haga; Dorte Terp Andersen; Elisabeth Peen
Journal:  Clin Rheumatol       Date:  2011-01-14       Impact factor: 2.980

5.  Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome.

Authors:  E Borda; J J Camusso; C Perez Leiros; S Bacman; O Hubscher; R Arana; L Sterin-Borda
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 6.  Current concepts on Sjögren's syndrome - classification criteria and biomarkers.

Authors:  Roland Jonsson; Karl A Brokstad; Malin V Jonsson; Nicolas Delaleu; Kathrine Skarstein
Journal:  Eur J Oral Sci       Date:  2018-10       Impact factor: 2.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.